Actinomycotic canaliculitis: resolution following surgery and short topical antibiotic treatment
Purpose: This study aimed to study the incidence and clinical characteristics of patients diagnosed with actinomycotic canaliculitis in Iceland.Methods: We present a nationwide, retrospective case series for which cases were identified by searches of hospital diagnostic registries and pathology databases. Case histories were reviewed and histopathological analysis repeated to confirm the diagnosis.Results: Nine cases of actinomycotic canaliculitis were diagnosed in Iceland during 1988[ndash]2007. Subjects included six women and three men and represented 16% of all patients diagnosed with actinomycosis in the country. The incidence was 0.16 cases/100 000 inhabitants/year. Age-specific incidence rates were 0.59 cases/100 000 inhabitants/year for the 40[ndash]59-year-old age group and 1.37 cases/100 000 inhabitants/year for individuals aged 60[ndash]79 years. All patients underwent a three-way snip procedure and 1 week of topical antibacterial therapy.Conclusions: Actinomycotic canaliculitis is an uncommon condition which frequently eludes diagnosis. Topical antibiotics for 1 week may be sufficient following surgery, a finding which contrasts with previous reports.
Similar Posts:
- Multiple sclerosis incidence in the Faroe Islands 1986–2007
- Clinical characteristics and factors associated the outcome of lacrimal canaliculitis
- Effect of Chronic Beta-Blocker Use on Stroke After Noncardiac Surgery
- Terson’s syndrome as a prognostic factor for mortality of spontaneous subarachnoid haemorrhage
- Cancer Incidence among Patients with Alcohol Use Disorders–Long-Term Follow-Up
- The Value of PET in Mild Cognitive Impairment, Typical and Atypical/Unclear Dementias: A Retrospective Memory Clinic Study
- Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy
- Non-vitrectomizing vitreous surgery for premacular haemorrhage
- Occurrence of human papillomavirus in pterygia
- Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma